Benzinga | May 5, 2021 07:55AM EDT

Arbutus Biopharma Q1 EPS $(0.21) Beats $(0.23) Estimate, Sales $2.11M Miss $3.31M Estimate

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 16 percent increase over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $2.11 million which missed the analyst consensus estimate of $3.31 million by 36.16 percent. This is a 41.72 percent increase over sales of $1.49 million the same period last year.